Global Rho Kinases Rocks Inhibitor Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 61.40 Billion |
 Market Size (Forecast Year) |
USD 102.38 Billion |
 CAGR |
% |
| Major Markets Players |
全球 Rho 激酶 (ROCKs) 抑制剂市场，按药物（Netarsudil、Ripasudil 盐酸盐水合物、Fasudil 等）、适应症（脑血管痉挛、青光眼等）、给药途径（口服、外用、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2030 年。
Rho 激酶 (ROCK) 抑制剂市场分析和规模
癌症患者人数的增加和寻求新疗法的人数的增加可以作为 Rho 激酶 (ROCKs) 抑制剂市场增长的积极迹象。除此之外，强大的研发活动也可以提高市场地位。目前，许多公司正在该领域开展工作，创建了超过 12 种活性产品的强大产品线。
Data Bridge Market Research 分析了 2023-2030 年预测期内 Rho 激酶 (ROCKs) 抑制剂市场的增长率。在上述预测期内，Rho 激酶 (ROCKs) 抑制剂市场的预期复合年增长率约为 6.60%。2022 年市场价值为 614 亿美元，到 2030 年将增长至 1023.8 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
Rho 激酶 (ROCK) 抑制剂市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
药物（奈他舒地尔、利帕舒地尔盐酸盐、法舒地尔等）、适应症（脑血管痉挛、青光眼等）、给药途径（口服、外用、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Kowa Pharmaceuticals America, Inc.（美国）、Senju Pharmaceutical Co.,Ltd.（日本）、Novartis AG（瑞士）、AERIE PHARMACEUTICALS, INC.（美国）、Redx Pharma Plc（英国） |
|
市场机会 |
|
Market Definition
Rho kinases (ROCKs) inhibitor is a type of rho-associated protein kinase inhibitor a therapeutics belonging to the serine-threonine family. Their function is to target the small GTP-binding protein Rho network that plays an essential role in regulating cell cycle control. ROCK is recommended to be a therapeutic target in several diseases such as ophthalmic diseases, cardiovascular diseases, neurological disorders, autoimmune diseases, and cancer.
Rho Kinases (ROCKs) Inhibitors Market Dynamics
Drivers
- Growing Prevalence of Cancer
Cancer is one of the leading cause of death worldwide, accounting for around 10 million deaths in 2020. The most common in 2020 was breast cancer, about 2.26 million cases. Breast cancer is the most common type, with 290,560 new cases anticipated in the U.S. in 2022. The next most incident cancers are prostate cancer and lung cancer. There was an expected 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020 worldwide. Thus, this factor increases the demand of Rho Kinases (ROCKs), further boosting the market growth.
Opportunities
- Increasing Cases of Glaucoma
Glaucoma is a top cause of irreversible blindness in the U.S. and the world. More than three million Americans are surviving with glaucoma, and 2.7 million people aged 40 years and older are affected by its most common form, open-angle glaucoma. Blindness or low vision affects around 3.3 million Americans age 40 years and above. More than 11 million individuals are expected to be bilaterally blind because of glaucoma in 2020. In the majority of the cases, blindness can be prevented with proper control and treatment. In the U.S., blindness is the third most feared health problem, after cancer and cardiac attacks. In this regard, ROCK inhibitors are used to decrease intraocular pressure, which is found to be beneficial for glaucoma, by smoothening the trabecular meshwork cells of the eye which is critical for the drainage of ocular fluid. Thus, this factor helps in increasing the market growth.
- Growing Healthcare Expenditure And Government Support
The rising incidence of cancer, the growing awareness for the disease and the associated treatment is also enhancing. Numerous government initiatives tend to provide better and more convenient treatments and favourable reimbursement policies that are anticipated to increase the industry growth. Additionally, growing acceptance of advanced therapies is projected to drive the market.
Restraints/Challenges
- High Cost of Treatment
The increasing expenditure related with the medications hinder the market growth. Numerous genetic drugs cost high and people in developing and underdeveloped countries, causing the under treatment of several patients. This impedes the market growth.
本 Rho 激酶 (ROCKs) 抑制剂市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地理扩展、市场技术创新等方面的机会。如需了解有关 Rho 激酶 (ROCKs) 抑制剂市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球 Rho 激酶 (ROCK) 抑制剂市场范围
Rho 激酶 (ROCKs) 抑制剂市场根据药物、适应症、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
药物
- 奈他舒地尔
- 盐酸利帕舒地尔水合物
- 法舒地尔
- 其他的
指征
- 脑血管痉挛
- 青光眼
- 其他的
给药途径
- 口服
- 主题
- 其他的
最终用户
- 医院
- 家庭护理
- 专科诊所
- 其他的
分销渠道
- 医院药房
- 网上药店
- 零售药店
Rho 激酶 (ROCK) 抑制剂市场区域分析/见解
对 Rho 激酶 (ROCKs) 抑制剂市场进行了分析，并按上述药物、适应症、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。
Rho 激酶（ROCKs）抑制剂市场报告涵盖的主要国家 包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于青光眼发病率高、Rho 激酶 (ROCKs) 抑制剂疗法的认知度和开发活动不断增加，北美 Rho 激酶 (ROCKs) 抑制剂市场在整个预测期内一直呈现正增长态势。此外，精良临床设施的不断增加以及眼疾患者寻求更好治疗的比率激增也推动了市场的增长。
亚太地区由于医疗基础设施的健康改善和巨大的经济发展而占据市场主导地位。此外，医疗基础设施的健康改善促进了市场的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球 Rho 激酶 (ROCK) 抑制剂市场份额分析
Rho 激酶 (ROCKs) 抑制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对 Rho 激酶 (ROCKs) 抑制剂市场的关注有关。
Rho 激酶 (ROCK) 抑制剂市场的主要参与者包括：
- Kowa Pharmaceuticals America, Inc.（美国）
- 千寿制药株式会社（日本）
- 诺华公司（瑞士）
- AERIE PHARMACEUTICALS, INC.（美国）
- Redx Pharma Plc（英国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
